156 related articles for article (PubMed ID: 29516956)
1. Use of simultaneous radiation boost achieves high treatment response rate in patients with metastatic gastric cancer.
Yang J; Liu J; Gao S; Yang Y; Kong W; Ren W; Zhu L; Yang M; Wei J; Zou Z; Qian X; Liu B; Yan J
J Cancer Res Ther; 2018 Jan; 14(1):36-39. PubMed ID: 29516956
[TBL] [Abstract][Full Text] [Related]
2. Dose escalation in prostate radiotherapy up to 82 Gy using simultaneous integrated boost: direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy.
Dolezel M; Odrazka K; Vaculikova M; Vanasek J; Sefrova J; Paluska P; Zouhar M; Jansa J; Macingova Z; Jarosova L; Brodak M; Moravek P; Hartmann I
Strahlenther Onkol; 2010 Apr; 186(4):197-202. PubMed ID: 20354663
[TBL] [Abstract][Full Text] [Related]
3. Esophageal cancer dose escalation using a simultaneous integrated boost technique.
Welsh J; Palmer MB; Ajani JA; Liao Z; Swisher SG; Hofstetter WL; Allen PK; Settle SH; Gomez D; Likhacheva A; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):468-74. PubMed ID: 21123005
[TBL] [Abstract][Full Text] [Related]
4. Comparison of dosiology between three dimensional conformal and intensity-modulated radiotherapies (5 and 7 fields) in gastric cancer post-surgery.
Ma H; Han J; Zhang T; Ke Y
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):759-764. PubMed ID: 24142733
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison between three-dimensional conformal radiotherapy followed by electron beam boost and volumetric modulated arc therapy using concomitant boost for the heart and cardiac segments in patients with left-sided breast cancer at risk for radiation-induced cardiac toxicity.
Murakami Y; Murakami Y; Kamima T; Oguchi M; Abo N; Takahashi T; Kaneko M; Nakano M; Matsubayashi F; Harada A; Taguchi S; Hashimoto T; Yoshioka Y
Phys Med; 2022 Mar; 95():126-132. PubMed ID: 35158316
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer.
Minn AY; Hsu A; La T; Kunz P; Fisher GA; Ford JM; Norton JA; Visser B; Goodman KA; Koong AC; Chang DT
Cancer; 2010 Aug; 116(16):3943-52. PubMed ID: 20564136
[TBL] [Abstract][Full Text] [Related]
7. Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trial.
Forster T; Hommertgen A; Häfner MF; Arians N; König L; Harrabi SB; Schlampp I; Köhler C; Meixner E; Heinrich V; Weidner N; Hüsing J; Sohn C; Heil J; Golatta M; Hof H; Krug D; Debus J; Hörner-Rieber J
Radiother Oncol; 2021 Oct; 163():165-176. PubMed ID: 34480960
[TBL] [Abstract][Full Text] [Related]
8. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
[TBL] [Abstract][Full Text] [Related]
9. Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas.
Fuji H; Schneider U; Ishida Y; Konno M; Yamashita H; Kase Y; Murayama S; Onoe T; Ogawa H; Harada H; Asakura H; Nishimura T
Radiat Oncol; 2013 Nov; 8():255. PubMed ID: 24180282
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers.
Spiotto MT; Weichselbaum RR
PLoS One; 2014; 9(4):e94456. PubMed ID: 24714187
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.
Kam MK; Chau RM; Suen J; Choi PH; Teo PM
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):145-57. PubMed ID: 12694833
[TBL] [Abstract][Full Text] [Related]
12. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
[No Abstract] [Full Text] [Related]
13. Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma.
Fakhrian K; Oechsner M; Kampfer S; Schuster T; Molls M; Geinitz H
Strahlenther Onkol; 2013 Apr; 189(4):293-300. PubMed ID: 23443611
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
[No Abstract] [Full Text] [Related]
15. Comparison of intensity modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) and a 3-dimensional conformal parotid gland-sparing radiotherapy (ConPas 3D-CRT) in treatment of nasopharyngeal carcinoma: a mono-institutional experience.
Bišof V; Rakušić Z; Bibić J; Grego T; Soče M
Radiol Med; 2018 Mar; 123(3):217-226. PubMed ID: 29094268
[TBL] [Abstract][Full Text] [Related]
16. Single-arc volumetric-modulated arc therapy (sVMAT) as adjuvant treatment for gastric cancer: dosimetric comparisons with three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT).
Wang X; Li G; Zhang Y; Bai S; Xu F; Wei Y; Gong Y
Med Dosim; 2013; 38(4):395-400. PubMed ID: 23791504
[TBL] [Abstract][Full Text] [Related]
17. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study.
Wu Q; Manning M; Schmidt-Ullrich R; Mohan R
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):195-205. PubMed ID: 10656393
[TBL] [Abstract][Full Text] [Related]
18. Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique.
Borghetti P; Pedretti S; Spiazzi L; Avitabile R; Urpis M; Foscarini F; Tesini G; Trevisan F; Ghirardelli P; Pandini SA; Triggiani L; Magrini SM; Buglione M
Radiat Oncol; 2016 Apr; 11():59. PubMed ID: 27094398
[TBL] [Abstract][Full Text] [Related]
19. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
[TBL] [Abstract][Full Text] [Related]
20. Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.
Wang D; Bi N; Zhang T; Zhou Z; Xiao Z; Liang J; Chen D; Hui Z; Lv J; Wang X; Wang X; Deng L; Wang W; Wang J; Wang C; Lu X; Xu K; Wu L; Xue W; Feng Q; Wang L
Radiat Oncol; 2019 Jun; 14(1):106. PubMed ID: 31196118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
